A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma
- Determine the efficacy of radiotherapy in the prevention of metastatic skin nodules or
tumor seeding following invasive diagnostic procedures, such as chest drain insertion,
pleural aspiration, pleural biopsy, and thoracoscopy, in patients with malignant
- Determine whether the nodules that develop after radiotherapy are symptomatic in these
- Compare the quality of life of patients treated with radiotherapy vs standard care
OUTLINE: This is a randomized study.
Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive radiotherapy on 3 consecutive days beginning within 3 weeks
after chest drain insertion, pleural aspiration, pleural biopsy, or thoracoscopy and
once the wounds have healed.
- Arm II: Patients receive standard supportive care alone. Quality of life is assessed at
baseline, and then at 1, 2, 4, 6, 9, and 12 months.
Patients are followed at 1, 2, 4, 6, 9, and 12 months.
PROJECTED ACCRUAL: A total of 44 patients (22 per arm) will be accrued for this study within
Primary Purpose: Treatment
Incidence of metastatic skin nodules
Noelle O'Rourke, MD
University of Glasgow
United States: Federal Government